InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
5.78
+0.10 (1.76%)
At close: Aug 28, 2026, 4:00 PM EDT
5.72
-0.06 (-1.04%)
After-hours: Aug 28, 2026, 7:30 PM EDT
InterCure Market Cap
InterCure has a market cap or net worth of $64.74 million as of August 28, 2026. Its market cap has decreased by -28.49% in one year.
Market Cap
64.74M
Enterprise Value
110.43M
1-Year Change
-28.49%
Ranking
Category
Stock Price
$5.78
ChartMarket Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.77M to $64.74M, an increase of 3,560.97%. That is a compound annual growth rate of 25.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 64.74M | 16.63% |
| Dec 31, 2025 | 55.50M | -25.61% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 142.99M |
| Cumberland Pharmaceuticals | 129.60M |
| BGM Group | 116.86M |
| Citius Oncology | 83.58M |
| Zhengye Biotechnology Holding | 83.41M |
| Talphera | 63.84M |
| SCYNEXIS | 54.92M |
| Incannex Healthcare | 44.15M |